A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia.
Prithviraj BoseSrdan VerstovsekJorge E CortesSusan TseYvonne GasiorNitin JainElias J JabbourZeev EstrovYesid AlvaradoCourtney D D DiNardoNaveen PemmarajuSteven Mitchell KornblauTapan Mahendra KadiaNaval G DaverKiran NaqviNicholas J ShortLucia MasarovaJohn VillarealSherry A PierceGraciela Nogueras GonzalezXuelin HuangGuillermo Garcia-ManeroHagop M KantarjianFarhad RavandiPublished in: Leukemia (2020)